REGEN BIOPHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-5.1M | $727.2K |
| FY2022 | — | $-76.7M | $51.2K |
| FY2023 | — | $-4.9M | $121.0K |
| FY2024 | — | $-5.2M | $716 |
| FY2025 | — | $-6.3M | $69.6K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-5.1M | $727.2K |
| FY2022 | — | $-76.7M | $51.2K |
| FY2023 | — | $-4.9M | $121.0K |
| FY2024 | — | $-5.2M | $716 |
| FY2025 | — | $-6.3M | $69.6K |